Comparison of the effectiveness of repeated injections of onabotulinum toxin A for refractory idiopathic detrusor overactivity: analysis of an open label extension of a randomized trial (the RELAX study)
Sign Up to like & getrecommendations! Published in 2017 at "Neurourology and Urodynamics"
DOI: 10.1002/nau.23095
Abstract: To assess effects of repeat treatment with onabotulinumtoxin A (onaBoNT‐A) in women with refractory idiopathic detrusor overactivity (DO). read more here.
Keywords: detrusor overactivity; refractory idiopathic; idiopathic detrusor; comparison effectiveness ... See more keywords
Onabotulinum toxin A in children with refractory idiopathic overactive bladder: medium-term outcomes.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of pediatric urology"
DOI: 10.1016/j.jpurol.2018.08.007
Abstract: INTRODUCTION Botulinum toxin-A (BtA) has been used for refractory idiopathic overactive bladder (IOAB) in children. Data on the optimum dose success rates, duration of effect, complications and medium-term outcomes are limited. This study aims to… read more here.
Keywords: idiopathic overactive; medium term; refractory idiopathic; bladder ... See more keywords
Biologics in refractory idiopathic inflammatory myositis (IIM): What experience in juvenile vs adult myositis tells us about the use of biologics in pediatric IIM
Sign Up to like & getrecommendations! Published in 2021 at "Modern Rheumatology"
DOI: 10.1080/14397595.2021.1881027
Abstract: Abstract Juvenile dermatomyositis (JDM) is an extremely heterogeneous orphan disease with limited amount of dedicated research on the subject matter. Recent research suggests that JDM may not just be the classic antibody driven complements mediated… read more here.
Keywords: biologics refractory; refractory idiopathic; treatment; juvenile ... See more keywords
Low dose rituximab is efficacious in refractory idiopathic inflammatory myopathies.
Sign Up to like & getrecommendations! Published in 2022 at "Rheumatology"
DOI: 10.1093/rheumatology/keac438
Abstract: OBJECTIVES Rituximab use early in the course of refractory idiopathic inflammatory myopathy(IIM) is not well studied. This study sought to determine the short-term efficacy of RTX in a registry based cohort of refractory IIM. METHODS… read more here.
Keywords: refractory; registry based; idiopathic inflammatory; refractory idiopathic ... See more keywords